Zapping AFib: new heart procedure trial seeks to control irregular heartbeat
Disease control
Not yet recruiting
This study is testing a new medical device called the CellFX system, which uses brief electrical pulses to treat a common type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). The goal is to see if this procedure is safe and effective for people whose AFib sym…
Phase: NA • Sponsor: Pulse Biosciences, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC